Oracle has launched Oracle Pedigree and Serialisation Manager, an integrated mass-serialisation and pedigree application designed to improve supply chain integrity in the pharmaceutical industry. It can also be used in medical device industry dealing in high-value products at risk for counterfeiting and piracy.
Oracle claimed that the new solution helps pharmaceutical and medical device manufacturers facilitate compliance with emerging electronic pedigree (ePedigree) initiatives and regulatory requirements, reduce business and reputational risk associated with the rising incidence of drug counterfeiting and product diversion while extending value across the pharmaceutical supply chain.
Additionally, Oracle’s new solution generates, stores, transmits and authenticates drug product serial data and ePedigree data as pharmaceutical products move across the supply chain.
The new solution facilitates counterfeit threat identification and streamlines compliance. Integrated analytics within the solution provide pharmaceutical and medical manufacturers with expanded insight into possible threats.
Oracle said that the solution can be used by pharmaceutical and medical device companies to improve the efficiency and accuracy of returns management and reduce associated losses.
Further, the software helps pharmaceutical companies maintain channel integrity by enabling them to reduce product diversions, such as from lower reimbursement locations to higher reimbursement locations. It also can help reduce revenue leakage by helping to improve scrutiny of chargeback rebates paid out to wholesalers.
Oracle Pedigree and Serialisation Manager is built on an open standards-based Service-Oriented Architecture (SOA) and Oracle Fusion Middleware applications to integrate seamlessly with existing Oracle and third-party systems for manufacturing, packaging and shipping and receiving.